Peer-reviewedCC BY 4.0Journal of Biological Chemistry
Ribonucleotide Reductase Dysregulation in Cancer – Oncogenic Hijacking and Novel Therapies: Teaching an Old Dog New Tricks
Related
- Hijacking Cellular S-Acylation with Molecular Assemblies Rewires Oncogenic Signaling
- An oxidized ribonucleotide 8-oxoGTP drives neuroinflammation and accelerates cognitive decline
- Hijacking the Message: Insights from Targeting mRNA Export and Translation in AML
- Ribonuclease H1 Hijacking: Oncotherapeutics through MicroRNA-Triggered Intracellular Construction of Long DNA/RNA Heteroduplexes
- Allosteric inhibition of human mitochondrial ClpP by hijacking the dordaviprone (ONC201) binding site
BibTeX
@article{brzozowski2026ribonucleotide,
title = {{Ribonucleotide Reductase Dysregulation in Cancer – Oncogenic Hijacking and Novel Therapies: Teaching an Old Dog New Tricks}},
author = {Taylor L. Brzozowski and Mary C. Vincent and Ruth A. Keri},
journal = {Journal of Biological Chemistry},
year = {2026},
month = nov,
doi = {10.1016/j.jbc.2026.113710},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0021925826025822},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Ribonucleotide Reductase Dysregulation in Cancer – Oncogenic Hijacking and Novel Therapies: Teaching an Old Dog New Tricks
AU - Taylor L. Brzozowski
AU - Mary C. Vincent
AU - Ruth A. Keri
PY - 2026
DA - 2026/11/01
JO - Journal of Biological Chemistry
DO - 10.1016/j.jbc.2026.113710
UR - https://linkinghub.elsevier.com/retrieve/pii/S0021925826025822
SN - 0021-9258
ER -